Note 12 - Share Based Compensation - Restricted Stock Activity (Details) - The 2023 Equity Plan [Member] - Restricted Stock [Member] - $ / shares |
3 Months Ended | 9 Months Ended | |
|---|---|---|---|
Jun. 15, 2023 |
Sep. 30, 2023 |
Sep. 30, 2023 |
|
| Outstanding, restricted stock awards (in shares) | 187,200 | 0 | |
| Outstanding, weighted average grant date fair value (in dollars per share) | $ 9.36 | $ 0 | |
| Granted, restricted stock awards (in shares) | 187,200 | 0 | 187,200 |
| Granted, weighted average grant date fair value (in dollars per share) | $ 0 | $ 9.36 | |
| Forfeited, restricted stock awards (in shares) | 0 | 0 | |
| Forfeited, weighted average grant date fair value (in dollars per share) | $ 0 | $ 0 | |
| Outstanding, restricted stock awards (in shares) | 187,200 | 187,200 | |
| Outstanding, weighted average grant date fair value (in dollars per share) | $ 9.36 | $ 9.36 |
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|